Nanomedicine for the Detection and Treatment of Ocular Bacterial Infections

Abstract

Ocular bacterial infection is a prevalent cause of blindness worldwide, with substantial consequences for normal human life. Traditional treatments for ocular bacterial infections are ineffective, necessitating the development of novel techniques to enable accurate diagnosis, precise drug delivery, and effective treatment alternatives. With the rapid advancement of nanoscience and biomedicine, increasing emphasis has been placed on multifunctional nanosystems to overcome the challenges posed by ocular bacterial infections. Given the advantages of nanotechnology in the biomedical industry, it can be utilized to diagnose ocular bacterial infections, administer medications, and treat them. In this review, the recent advancements in nanosystems for the detection and treatment of ocular bacterial infections are discussed; this includes the latest application scenarios of nanomaterials for ocular bacterial infections, in addition to the impact of their essential characteristics on bioavailability, tissue permeability, and inflammatory microenvironment. Through an in‐depth investigation into the effect of sophisticated ocular barriers, antibacterial drug formulations, and ocular immune metabolism on drug delivery systems, this review highlights the challenges faced by ophthalmic medicine and encourages basic research and future clinical transformation based on ophthalmic antibacterial nanomedicine.This article is protected by copyright. All rights reserved

Microneedle System with Biomarker-Activatable Chromophore as Both Optical Imaging Probe and Anti-bacterial Agent for Combination Therapy of Bacterial-Infected Wounds and Outcome Monitoring

“…coli probably due to the synergistic antibacterial efficacy of the activated probe FQ-OH and TA in the MNs. The formation of biofilm in infected wounds is a persistent clinical challenge, which facilitates bacterial evasion of antibiotic eradication and ultimately leads to the emergence of chronic and resistant infections. − ,, MNs have been regarded as a highly promising means for destructing formed biofilms and consequently delivering antibacterial drugs into skin wounds. − Therefore, it is crucial to evaluate the efficacy of FM@ST MN in inhibiting the formation of biofilm and destructing the formed biofilm so as to obtain a comprehensive assessment of its antibacterial properties. Hence, S.…”

CuS/Co-Ferrocene-MOF Nanocomposites for Photothermally Enhanced Chemodynamic Antibacterial Therapy

“…Bacterial infection has become a serious threat to public health. − Antibiotics have long been the most effective drugs against bacterial infections, but the overuse of antibiotics has led to an increased rate of illness and increased microbial resistance to antibiotics. − Therefore, the development of emerging functional nanomaterials or antibacterial technologies with antidrug-resistant and anti-infective properties will help protect wounds and treat drug-resistant bacterial infections. − Chemodynamic therapy (CDT) is a promising antibacterial therapy that harnesses Fenton or Fenton-like reactions catalyzed by nanomaterials to generate hydroxyl radical (·OH) from H 2 O 2 in the infected microenvironment to induce bacterial death. − The advancement of potent Fenton or Fenton-like reagents is crucial for achieving effective CDT, making it a central focus in the field of nanomedicine. In the past decade, there have been several promising Fenton or Fenton-like reagents introduced and developed for CDT, such as noble metal-based nanomaterials, , metal oxide-based nanomaterials, − carbon-based nanomaterials, − and metal–organic frameworks (MOF)-based nanomaterials. − Among them, the porous nano-MOF have been extensively studied in biomedical fields recently due to their low toxicity and good biocompatibility. − However, they usually display limited or insignificant Fenton-like catalytic activity, which hinders their effectiveness for CDT.…”